A Closer Look at the Use of Placental Membranes for Wound Closure
Debilitating chronic wounds, including diabetic foot ulcers and venous ulcers, affect millions of patients in the United States every year. A growing body of research shows that treatment-refractory chronic wounds may respond well to the use of placental tissues.
This guide, sponsored by Smith+Nephew, makers of GRAFIX and STRAVIX, discusses the challenges of chronic wound care and the encouraging results observed with placental tissue products in the treatment of these difficult wounds. The guide also provides case studies of successful GRAFIX and STRAVIX use in patients with foot ulcers and infections, as well as post-surgical tendon rupture.
Wound care professionals will be interested in these advanced wound care products, which have shown promising results in the treatment of hard-to-heal chronic wounds.
This white paper contains information on the following topics:
This paper is written for wound care clinicians and purchasing directors with an interest in product solutions. This paper was developed by an independent third party.
Sponsored by Smith+Nephew, Inc.